Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Disease area: Interstitial lung diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Alvarenga Santos (Lisboa, Portugal), S. Clemente (Lisboa, Portugal), M. Felizardo (Lisboa, Portugal), S. Furtado (Lisboa, Portugal). Connective tissue disease-related interstitial lung disease and lung cancer. 2986

Member's Comments

No comment yet.

Related content which might interest you: Connective tissue disease-associated lung disease Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Connective tissue disease-associated lung disease Source: ERS Course 2019- Interstitial Lung Diseases Year: 2018 Connective tissue disease-associated lung disease Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Connective tissue disease-associated lung disease Source: ERS Course 2016 Year: 2016 Connective tissues disease-associated lung disease Source: School Course 2014 - Interstitial lung diseases Year: 2014 Lung cancer and interstitial lung disease Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Rituximab in severe, treatment-refractory interstitial lung disease Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Plethysmographic profil of patients with infiltrative lung diseases Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Connective tissue disease-associated lung disorders Source: Eur Respir Mon; 2009: 46: 225–250 Year: 2009 Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27 Year: 2005 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Chemical exposure triggering connective tissue disease with lung involvement Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases Source: International Congress 2017 – Rare diseases Year: 2017 Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016